What Is a Mast Cell? Function, Triggers & Disease

A mast cell is a type of immune cell that lives in your tissues and acts as one of your body’s first responders to injury, infection, and allergens. These cells are best known for triggering allergic reactions, but they do far more than that. They help heal wounds, fight off pathogens, grow new blood vessels, and coordinate signals between your immune system and nervous system. When mast cells malfunction, the results range from common allergies to rare, serious conditions like mastocytosis.

Where Mast Cells Come From

Mast cells begin as stem cells in your bone marrow. They develop through a series of precursor stages, but unlike most immune cells, they don’t fully mature before entering your bloodstream. Instead, immature mast cell precursors circulate through your blood as small, featureless cells without their signature granules. They only finish developing after they settle into a specific tissue, where the local chemical environment shapes what kind of mast cell they become.

This final maturation step depends heavily on a growth factor called stem cell factor, which binds to a receptor on the mast cell surface. Other signaling molecules from nearby cells fine-tune the process. The result is that mast cells in your skin look and behave differently from mast cells in your gut or lungs. Your body essentially customizes each mast cell for the tissue it lives in.

Where They Live in Your Body

Mast cells concentrate at the boundaries between your body and the outside world. They’re densely packed in your skin, the lining of your airways, and the walls of your digestive tract. You’ll also find them in the bladder, lymph nodes, around blood vessels, and in connective tissue throughout the body. This positioning is strategic: they sit right where bacteria, allergens, and parasites are most likely to enter.

Scientists have identified two broad categories. Connective tissue mast cells live in the skin, muscle, and the cavity surrounding your organs. Mucosal mast cells line the gut and lungs. Recent research using gene expression mapping has found at least six distinct mast cell subtypes in humans, distributed unevenly across at least 12 organs. Skin mast cells, for example, express genes involved in skin-specific maintenance that mast cells in other organs don’t. Lung mast cells carry their own unique genetic signature tied to airway function.

How Mast Cells Get Activated

The classic activation pathway involves allergies. Each mast cell is studded with receptors that grab onto IgE antibodies, the type your body produces in response to allergens. These antibodies sit on the mast cell surface like loaded mousetraps. When an allergen (pollen, pet dander, a food protein) comes along and bridges two of these antibodies together, the receptor fires a signal cascade inside the cell. Within seconds, the mast cell releases its payload of preloaded chemicals in a process called degranulation.

Even without an allergen present, IgE antibodies bound to mast cells send low-level survival signals that keep the cell alive longer. When an allergen does arrive and the cell degranulates, the response can be amplified further if stem cell factor is also present, creating a synergistic effect that intensifies the reaction.

Non-Allergic Triggers

Allergies get the most attention, but mast cells respond to a surprisingly wide range of signals that have nothing to do with IgE. They can be activated by complement proteins (part of your innate immune system), by neuropeptides released from nearby nerve endings, by certain medications, by physical stimuli like heat or pressure, and by bacterial products detected through pattern recognition receptors on their surface. Stress hormones can even trigger them: corticotropin-releasing hormone, the same molecule your hypothalamus releases under psychological stress, binds to receptors on mast cells and causes them to selectively release factors that increase blood vessel permeability. This is one reason stress can worsen allergic and inflammatory conditions.

Some drugs activate mast cells through a receptor called MRGPRX2, which responds to a variety of positively charged molecules. Several FDA-approved injectable medications and certain contrast dyes can trigger this pathway, producing allergy-like reactions in people who aren’t technically allergic to anything.

What Mast Cells Release

When a mast cell degranulates, it dumps the contents of hundreds of tiny internal packets called granules. The most famous of these chemicals is histamine, which causes blood vessels to widen, tissues to swell, and itching to start. Histamine is also why your nose runs during an allergic reaction, why hives appear on your skin, and why your stomach produces excess acid during a flare.

But histamine is just one item in a large arsenal. Mast cells release enzymes called tryptase and chymase that break down surrounding tissue (useful during wound repair, problematic during chronic inflammation). They produce signaling molecules that recruit other immune cells to the area. They generate lipid-based mediators that contract smooth muscle in your airways, contributing to wheezing. And they secrete growth factors that promote the formation of new blood vessels. The specific cocktail of chemicals varies depending on the tissue: a skin mast cell doesn’t release the same profile as a gut mast cell, even when both are responding to the same type of signal.

Their Role in Wound Healing

Mast cells are early and active participants in tissue repair. When you’re injured, mast cells near the wound release inflammatory signals that kick-start the healing process. Their enzymes, tryptase and chymase, break down the damaged extracellular matrix to clear the way for new tissue growth. Tryptase also directly stimulates fibroblasts, the cells responsible for producing collagen, which forms the structural scaffold of healing tissue.

As healing progresses, mast cells shift to supporting the growth of new blood vessels, a process called angiogenesis. They release vascular endothelial growth factor and fibroblast growth factor, and their enzymes free additional growth-promoting fragments trapped in the surrounding matrix. Chymase levels peak around the fifth day after injury, coinciding with the appearance of new blood vessels in the wound. Mast cells also drive wound contraction, the process that pulls the edges of a wound closer together, through histamine and tryptase signaling to fibroblasts.

Defense Against Pathogens and Toxins

Mast cells are positioned as sentinels at tissue barriers, and they contribute to your defense against parasites, bacteria, and venoms. Their ability to rapidly release inflammatory mediators helps contain infections before your adaptive immune system has time to respond. They detect bacterial components through pattern recognition receptors and recruit neutrophils and other immune cells to the site of invasion through complement-dependent pathways.

One compelling theory, known as the “toxin hypothesis,” proposes that allergic-type responses evolved as a defense mechanism against venoms and environmental toxins. Under this model, the same IgE-driven mast cell response that causes you to swell up from a bee sting originally served to neutralize venom by flooding the area with enzymes and increasing blood flow. The misfire of this system against harmless proteins like pollen is what we experience as allergies.

Mast Cell Activation Syndrome

In some people, mast cells become overactive without a clear allergic trigger, releasing mediators inappropriately and causing symptoms across multiple organ systems. This condition is called mast cell activation syndrome, or MCAS. Diagnosis requires meeting three criteria: episodic symptoms involving at least two organ systems (such as flushing and diarrhea, or hives and wheezing), improvement with medications that block mast cell mediators, and laboratory evidence that mast cell mediators are elevated during symptomatic episodes.

The most commonly measured marker is serum tryptase, an enzyme released almost exclusively by mast cells. The normal reference range for baseline tryptase is 1 to 15 ng/mL. In MCAS, doctors look for a rise above a patient’s personal baseline during a flare, documented on at least two separate occasions. Persistently elevated tryptase above 15 ng/mL raises suspicion for a different condition: systemic mastocytosis.

Systemic Mastocytosis

Systemic mastocytosis is a condition in which abnormal mast cells accumulate in organs, most commonly the bone marrow. Over 90% of cases are driven by a specific mutation in the KIT gene, typically a single amino acid change called D816V. This mutation causes the growth factor receptor on mast cells to stay permanently switched on, leading to uncontrolled mast cell proliferation.

The disease ranges in severity. Non-advanced forms, including indolent systemic mastocytosis and bone marrow mastocytosis, often cause symptoms from excess mediator release (flushing, gastrointestinal problems, low blood pressure) but don’t damage organs. Advanced forms, including aggressive systemic mastocytosis and mast cell leukemia, involve organ damage and require more intensive treatment.

Medications That Target Mast Cells

Mast cell stabilizers are drugs that prevent degranulation, keeping the cell from dumping its contents. The oldest and best-known example, cromolyn sodium, has been used for decades to prevent asthma attacks and treat allergic eye conditions. It works by interrupting the signaling cascade between receptor activation and calcium influx, the final step that triggers granule release. A related drug, nedocromil sodium, is more effective at blocking histamine release from lung and throat mast cells at higher concentrations.

Newer agents combine mast cell stabilizing properties with antihistamine activity, giving them a dual mechanism. These second-generation stabilizers both prevent mediator release and block the effects of any histamine that does escape. For people with MCAS or mastocytosis, treatment typically layers multiple approaches: histamine blockers targeting two different receptor types, medications that block other mast cell products like leukotrienes, and sometimes cromolyn sodium to reduce overall mast cell reactivity.